GPR120 receptor agonists and uses thereof

Details for Australian Patent Application No. 2009335797 (hide)

Owner Metabolex, Inc.

Inventors Shi, Dong Fang; Song, Jiangao; Ma, Jingyuan; Novack, Aaron; Pham, Phuongly; Nashashibi, Imad; Rabbat, Christopher J.; Chen, Xin

Agent Griffith Hack

Pub. Number AU-A-2009335797

PCT Pub. Number WO2010/080537

Priority 61/138,923 18.12.08 US

Filing date 17 December 2009

Wipo publication date 15 July 2010

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 235/12 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/83 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 311/58 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 319/08 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 333/54 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/080537 Priority application(s): WO2010/080537

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335798-Covalent diabodies and uses thereof

2009335788-Hepatitis C virus combination therapy